DuPont de Nemours, Inc. (New York Stock Exchange:DD)

About the company

DuPont de Nemours, Inc. operates as a holding company, which engages in the development of specialty materials, chemicals, and agricultural products. It operates through the following segments: Electronics & Imaging; Nutrition & Biosciences; Transportation & Industrial; Safety & Construction, and Non-Core. The Electronics & Imaging segment provides permanent and process chemistries for the fabrication of printed circuit boards to include laminates and substrates, electroless and electrolytic metallization solutions, as well as patterning solutions and materials and innovative metallization processes for metal finishing, decorative, and industrial applications. The Nutrition & Biosciences segment provides solutions for the global food and beverage, dietary supplements, pharma, home and personal care, energy and animal nutrition markets. The Transportation & Industrial segment engineering resins, adhesives, silicones, lubricants and parts to engineers and designers in the transportation, electronics, healthcare, industrial and consumer end-markets to enable systems solutions for demanding applications and environments. The Safety & Construction segment provides engineering products and integrated systems for a number of industries including, worker safety, water purification and separation, aerospace, energy, medical packaging and building materials. The Non-Core segment supplier of key materials for the manufacturing of photovoltaic cells and panels, including SOLAMET metallization pastes, TEDLAR backsheet materials, and FORTASUN silicone encapsulants and adhesives. The company was founded in 1897 and is headquartered in Wilmington, DE.


Process Industries


Chemicals: Major Diversified




Edward D. Breen


New York Stock Exchange



Total Revenue




Market Capitalization


Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin


Operating Margin (in %)

Total operating margin


Net Margin (in %)

Total net margin


Dividend Yield (in %)

Dividend per share


Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
DuPont de Nemours, Inc. DD 40307.75 21319.00 1.01 -63.82 -3.00
Celanese Corp. CE 11052.78 6070.00 4.34 14.90 12.08
Eastman Chemical Co. EMN 9859.89 9134.00 1.60 12.24 8.85
Westlake Chemical Corp. WLK 7071.78 8025.00 1.19 14.31 6.17
Huntsman Corp. HUN 4170.12 6721.00 1.24 3.59 17.08
Huntsman Corp. HUN 4005.96 6721.00 1.19 3.45 17.08
Valvoline, Inc. VVV 3683.61 2427.00 -15.23 16.11 9.39
Element Solutions, Inc. ESI 2805.76 1829.00 1.27 37.79 4.24
Ingevity Corp. NGVT 2235.24 1304.00 4.37 10.88 15.82
Flexible Solutions International, Inc. FSI 23.52 27.00 1.26 11.53 7.91
IKONICS Corp. IKNX 7.08 18.00 0.60 -7.37 -5.38

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

If You Own DuPont de Nemours (DD) Stock, Should You Sell It Now?

5d ago, source: YAHOO!

If you are looking for the best ideas for your portfolio you may want to consider some of Amana Mutual Funds top stock picks.

DuPont de Nemours (DD)

4d ago, source: Forbes is the trade name of Quantalytics Holdings, LLC., LLC is a wholly owned subsidiary of Quantalytics Holdings, LLC (“Quantalytics”). Quantalytics is not a registered investment adviser ...

Dupont De Nemours Inc

12d ago, source: CNN

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer ...

DuPont de Nemours Outperform

12d ago, source: Business Insider

© 2020 Insider Inc. and GmbH All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Service and Privacy Policy ...

DuPont de Nemours Overweight

18d ago, source: Business Insider

© 2020 Insider Inc. and GmbH All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Service and Privacy Policy ...

Pharmaceutical Excipients Market Expected to Grow at a CAGR Of 5.01% by 2027|DuPont de Nemours, Inc., Roquette Freres, Ashland

14d ago, source: MarketWatch

This report also studies existing competitive scenario of some of the key players of the pharmaceutical excipients market, which includes profiling of DuPont de Nemours, Inc. (NYSE: DD), Roquette ...

DuPont de Nemours Inc.

29d ago, source:

DUPONT DE NEMOURS INC's gross profit margin for the first quarter of its fiscal year 2020 has increased when compared to the same period a year ago. Sales and net income have dropped ...

Portfolio items

Follow companies to create your optimal portfolio.
Refresh this page to see your newly added stocks.